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higher in patients treated with conventional radiotherapy. OS at 2 and 
5 years for the accelerated radiotherapy group were 16% and 3%, 
respectively, and 44% and 19% for the conventional radiotherapy group 
(P<0.00001). However, there was no statistical difference in LRC, 
DFS and DMFS between the two groups. LRC at 2 and 5 years for the 
accelerated radiotherapy group were 47% and 19%, compared to 48% 
and 37% for the conventional radiotherapy group. DFS at 2 and 5 years 
for the accelerated group were 24% and 10%, 30% and 19% for the 
conventional radiotherapy group. In terms of toxicity, 12 patients (11%) 
had Common Toxicity Criteria for Adverse Events (CTCAE) grade 3 or 
more treatment related pneumonitis. 6 patients (5%) had CTCAE grade 
3 acute esophagitis and only 1 patient had RTOG grade 3 late esopha-
geal toxicity.
Conclusions: In spite of treating the patients with poorer PF, acceler-
ated radiotherapy of 45 Gy in 15 fractions over 3 weeks achieved com-
parable local-regional control for Stage III NSCLC with conventional 
radiotherapy. Toxicity of accelerated radiotherapy was acceptable. 
Accelerated radiotherapy is reasonable strategy for patients who have 
locally advanced NSCLC with unfavorable prognostic factors, since 
their main goal of treatment is to improve their quality of life within a 
limited time. 
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Background: The diagnostic yield of TBNA can be highly variable, 
with a meta-analysis reporting the pooled sensitivity and speciﬁcity to 
be only 39% and 99%, respectively. Nodal position is often estimated 
from the distance between the carina and a visible lymph node, as mea-
sured on a diagnostic CT scan. However, breath-hold conventional CT 
scans do not account for nodal motion, and nodal motion may explain 
the lower yields when TBNA is performed without real-time ultrasound 
imaging. We studied mediastinal nodal motion on 4-dimensional (4D) 
CT scans.
Methods: A total of 47 distinct mediastinal nodes were identiﬁed on 
4DCT scans performed for radiotherapy planning in 25 patients with 
lung cancer. Nodes were mainly located at station 4R, 4L, 7 and 2R and 
each identiﬁed node was contoured in all 10 phases of the 4DCT. Nodal 
motion was derived from the displacement of the center of mass in the 
respiratory phases. In order to evaluate whether the distance between 
the center of mass of each node and the carina remained constant dur-
ing the respiratory cycle, this distance was derived for all respiratory 
phases using the coordinates of both structures. 
Results: The mean nodal diameter was 10.2 ± 4.0 mm (1SD) and mean 
nodal volume 1.8 ± 2.3 cc. Mobility was maximal in the cranio-caudal 
axis (mean of 4.7 ± 2.3 mm) and the corresponding medio-lateral and 
ventro-dorsal mobility was 2.8 ± 1.9 mm and 2.4 ± 1.8 mm, respec-
tively. The mean 3-dimensional displacement of nodal center was 6.2 ± 
2.9 mm, and this exceeded 10 mm in 5 nodes (Table 1). The nodal mass 
was constantly present in only 25 ± 14% of the region encompassing all 
nodal positions. The mean variation in cranio-caudal distance between 
all nodes and carina position during respiration was 5.3 ± 2.1 mm 
(range 2.2-10.5 mm). 
Conclusions: Both nodal motion and the varying distance between 
carina and nodal position, may explain the lower diagnostic yields for 
TBNA procedures performed without real-time guidance.
Table 1: Three-dimensional nodal mobility per location studied
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Translating research into routine clinical practice: image-guided 
lung stereotactic radiation therapy for unresectable patients with 
early stage lung cancer
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Background: Stereotactic Body Radiation Therapy (SBRT) has 
emerged as a non-invasive treatment option for unresectable early stage 
non-small cell lung cancer (NSCLC), delivering very high radio-abla-
tive doses of RT to the primary tumor. To ensure efﬁcacy of treatment 
and patient safety, high precision planning and careful treatment deliv-
ery under vigilant quality assurance are needed. We present the evolu-
tion of SBRT practice at Princess Margaret Hospital with an emphasis 
on accuracy of treatment set up and veriﬁcation using image-guided 
techniques.
Methods: From Oct 2004 to Feb 2007, we treated 46 patients (pts) 
with T1T2N0MO NSCLC with SBRT (48 tumors were treated). RT 
schedule for peripheral tumors was 60 Gy/3 fractions over 2 weeks (for 
29 tumors, 12 of the pts were part of the RTOG 0236 phase II study). 
When organ at risk tolerance doses were not achievable, either 54 
Gy/3 fr (3 pts) or 48 Gy/4 fr (10 tumors, all T1) was employed. Central 
tumors were treated with a lower dose of 50 Gy/10 fr schedule (6 pts). 
4DCT simulation was acquired in all but 9 pts who were too large for 
the scanner. All tumor and normal tissue contours and ﬁnal plans are 
reviewed in weekly multidisciplinary SBRT rounds. On the treatment 
unit, cone beam CT (CBCT) is used for image guidance with therapist 
manually matching directly to the tumor, adjusting the patient’s posi-
tion for discrepancies >3mm. CBCT is performed for initial localiza-
tion and repeated during treatment to verify the tumor position. We 
compared CBCT soft tissue (tumor) matching to bone matching (which 
would mimic matching used in conventional portal imaging). Patients 
are followed every 3 months with radiological and clinical assessment.
Results: Median pt age was 73 yrs (48-96); mean tumor size was 2.6 
cm (range 0.7-5.7). Median follow-up is 10 mo (range 0-26 mo). Acute 
RT toxicity was generally mild with grade G1 fatigue the most common 
